Shenzhen Kangtai Biological Products Co Ltd
SZSE:300601
Shenzhen Kangtai Biological Products Co Ltd
Operating Income
Shenzhen Kangtai Biological Products Co Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Shenzhen Kangtai Biological Products Co Ltd
SZSE:300601
|
Operating Income
¥292.2m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Operating Income
-¥12B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Operating Income
-¥1.1B
|
CAGR 3-Years
-36%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Operating Income
¥1.4B
|
CAGR 3-Years
22%
|
CAGR 5-Years
55%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Operating Income
¥9.9B
|
CAGR 3-Years
38%
|
CAGR 5-Years
46%
|
CAGR 10-Years
47%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Operating Income
¥1.4B
|
CAGR 3-Years
59%
|
CAGR 5-Years
72%
|
CAGR 10-Years
N/A
|
See Also
What is Shenzhen Kangtai Biological Products Co Ltd's Operating Income?
Operating Income
292.2m
CNY
Based on the financial report for Sep 30, 2023, Shenzhen Kangtai Biological Products Co Ltd's Operating Income amounts to 292.2m CNY.
What is Shenzhen Kangtai Biological Products Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
-11%
Over the last year, the Operating Income growth was -20%. The average annual Operating Income growth rates for Shenzhen Kangtai Biological Products Co Ltd have been -23% over the past three years , -11% over the past five years .